USL261

· UCB Biopharma S.P.R.L

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for USL261, covering 2018-11-27 to 2019-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters [Phase 3]